The commercialization of brain-computer interfaces is no longer the exclusive domain of American startups. A Chinese BCI implant is hitting the market, opening a new stage in the neurotechnology race and raising difficult questions about the privacy of our thoughts.
For years, discussions about connecting the human brain to computers were dominated by announcements from Silicon Valley and laboratory demonstrations. However, the balance of power is beginning to shift. Chinese scientists have commercialized their own brain-computer interface (BCI) implant, moving this technology from closed experiments to market practice.
What sets the Chinese BCI implant apart?
The design of the Chinese implant is based on three premises: miniaturization, procedural simplification, and lowered production costs. While some Western solutions require invasive neurosurgery, the Chinese interface has been designed to make the implantation procedure as minimally burdensome to the body as possible.
The device records impulses from the cerebral cortex and translates them into digital commands in real time. This allows patients with paralysis or severe motor dysfunctions to control a wheelchair, prosthesis, or mouse cursor solely through willpower. The small dimensions of the device also limit tissue damage and the risk of implant rejection.
China vs. Neuralink: Two visions of neurotechnology
The main point of reference in this industry remains Neuralink. The American concept is based on a dense network of flexible electrode threads placed in the brain by a specialized surgical robot. This provides high data throughput but comes with high costs and a complex procedure.
Chinese engineers have chosen a different path: they focus on pragmatism and mass availability. Instead of building an elite product, they focus on scalability. Just as in other branches of science — where autonomous scientific research is accelerating material breakthroughs — the Middle Kingdom is striving to shorten the path from prototype to mass application as much as possible.
Although the implant has gone on sale in the local market, its price still exceeds the means of the average citizen. For now, there is also no information about plans for foreign expansion or efforts to obtain certification in the West. This fits into a policy of protecting one's own resources — much like when China controls the transfer of key digital technologies.
Medical applications: From paralysis to Parkinson's
The development of BCI is primarily driven by regenerative medicine. However, the application of the implant goes far beyond helping people with spinal cord injuries. The device also opens up new possibilities in the therapy of neurodegenerative diseases:
- Parkinson's disease: Real-time monitoring of neuronal activity disorders and sending corrective impulses that suppress muscle tremors.
- Alzheimer's disease: Early detection of signal irregularities and stimulation of areas responsible for working memory.
- Post-stroke rehabilitation: Supporting brain neuroplasticity by closing the biofeedback loop during movement attempts.
Knowledge of the plasticity of the nervous system is still growing. Analyses show — similar to those studying how intense cognitive stimuli modify brain architecture — that targeted digital stimulation can stimulate the body's natural compensatory abilities.
Neuroethics and privacy: Can thoughts be hacked?
The commercialization of brain implants forces a redefinition of the concept of privacy. Existing biometrics have been based on fingerprints or facial scans. BCI interfaces go a step further — reaching directly into intentions and emotional reactions.
The greatest challenge of neurotechnology is no longer just reading the electrical signal from neurons, but creating a legal framework that will prevent the exploitation of a person's most private data.
Widespread access to BCI carries specific social and political challenges:
- Neural data protection: Interception of unencrypted signals from the implant by unauthorized entities.
- Profiling and behaviorism: Using information about a patient's emotional state for marketing or surveillance.
- Dual-use: Military potential, enabling the control of autonomous systems without the need for a keyboard or voice.
Challenges facing neuroengineering
Despite progress, neuroengineering is colliding with technological and biological limitations. There are approximately 86 billion neurons in the human brain, yet current implants pick up signals from only a fraction of that number. Our knowledge of how complex concepts are encoded remains highly fragmentary.
The second problem is long-term biocompatibility. The immune system's response to a foreign body, scar tissue around electrodes, or micro-movements of the implant are issues that will only be verified by years of patient observation. There is also a lack of universal safety standards for devices connected to the cerebral cortex.
Summary
The Chinese BCI implant is a clear signal that the competition in the field of neurotechnology is entering a new phase. The transition from prototype to market product proves the maturity of the project, although the price barrier and ethical issues still pose a major challenge. Regardless of the pace of implementation of this technology, the boundary between the human mind and digital systems is slowly blurring.
Sources
- https://www.scmp.com/tech/big-tech/article/3360684/china-completes-worlds-first-commercial-brain-computer-interface-implant
- https://www.neuralink.com/
- https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7144425/
- https://www.wired.com/story/brain-computer-interfaces-are-coming/
- https://www.theguardian.com/technology/2022/jan/12/brain-computer-interfaces-what-are-they-and-how-do-they-work
Comments